Issue: May 25, 2020

Read more

May 02, 2020
1 min read
Save

Cancer hospital appoints director of benign hematology

Issue: May 25, 2020
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Robert Bona, MD
Robert Bona

Robert Bona, MD, has been appointed director of the benign hematology program and professor of medicine at Smilow Cancer Hospital, part of Yale Cancer Center.

Bona also will serve as medical director of the Hemophilia Treatment Center for the pediatric hematology and oncology program at Smilow Cancer Hospital.

His appointment is effective July 1.

Bona has served as part-time member of the hematology department at Yale Cancer Center for 3 years.

He currently is founding faculty member and professor of medical sciences at Frank H. Netter MD School of Medicine at Quinnipiac University.

“We look forward to working more closely with Dr. Bona to build a comprehensive program for patients with inherited and acquired blood diseases,” Charles Fuchs, MD, MPH, director of Yale Cancer Center and physician-in-chief at Smilow Cancer Hospital, said in a press release.

Bona previously served as division chief and fellowship program director at University of Connecticut School of Medicine.